Ayman Al-Hendy to Amenorrhea
This is a "connection" page, showing publications Ayman Al-Hendy has written about Amenorrhea.
Connection Strength
0.528
-
LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids. Am J Obstet Gynecol. 2023 12; 229(6):662.e1-662.e25.
Score: 0.235
-
Efficacy and safety of vilaprisan in women with uterine fibroids: data from the ASTEROID 3 randomized controlled trial. F S Sci. 2023 Nov; 4(4):317-326.
Score: 0.233
-
Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study. Am J Obstet Gynecol. 2024 Feb; 230(2):237.e1-237.e11.
Score: 0.059